Vical Incorporated Share Price Nasdaq

Stocks

28/25/28	Fresh Tracks Therapeutics Announces Special Distribution	CI
16/24/16	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/23/21	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	CI
18/23/18	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from NASDAQ Composite Index	CI
13/23/13	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
20/23/20	Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	MT
20/23/20	US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	MT
20/23/20	Top Premarket Gainers	MT
20/23/20	Fresh Tracks Therapeutics' Board Approves Liquidation Plan; Shares Rise After Hours	MT
20/23/20	Fresh Tracks Therapeutics, Inc. Announces Chief Executive Officer Changes	CI
20/23/20	Fresh Tracks Therapeutics, Inc. Announces Executive Changes	CI
12/23/12	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
26/23/26	Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately	CI

14/22/14	Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating	MT
27/22/27	Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating	MT
16/22/16	HC Wainwright Adjusts Brickell Biotech's Price Target to $4.50 From $2, Keeps Buy Rating	MT
13/22/13	Lake Street Downgrades Brickell Biotech to Hold From Buy, Lowers Price Target to $0.25 From $2	MT
13/22/13	Oppenheimer Adjusts Brickell Biotech's Price Target to $1 From $4, Maintains Outperform Rating	MT

26/25/26	Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market	PR
29/25/29	Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution	AQ
28/25/28	/C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./	PR
06/24/06	Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company	PR
18/24/18	Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company	AQ

09/23/09	MÄRKTE USA/Uneinheitlich - Zinspfad ungewiss
08/23/08	MÄRKTE USA/Uneinheitlich - Zinssorgen bleiben präsent
08/23/08	MÄRKTE USA/Wall Street mit leichter Erholung
08/23/08	MÄRKTE USA/Wall Street stabilisiert nach Vortagesverlusten
08/23/08	MARKT USA/Wall Street stabilisiert nach Vortagesverlusten

1 day

+2.11%

Manager	Title	Age	Since
Albert Marchio CEO	Chief Executive Officer	74	-
Nancy Seretta CTO	Chief Tech/Sci/R&D Officer	-	01/01/2016
Aaron Fox-Collis DFI	Director of Finance/CFO	-	01/06/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VICAL INCORPORATED	+2.11%	-3.76%	-	-	55.85L
WUXI APPTEC CO., LTD.	-0.62%	-1.87%	+42.87%	+64.15%	6.38TCr
ARGENX SE	+0.35%	+3.20%	+14.40%	+81.76%	5.64TCr
LONZA GROUP AG	+0.53%	+1.96%	+16.24%	+103.35%	5.46TCr
IQVIA HOLDINGS INC.	-2.81%	-4.31%	+23.50%	+47.83%	4.41TCr
BEONE MEDICINES AG	-0.33%	-1.93%	+19.28%	+98.80%	4.21TCr
REVOLUTION MEDICINES, INC.	+0.55%	+2.31%	+225.14%	+866.21%	4.1TCr
GENMAB A/S	+3.27%	+47.96%	+112.84%	+96.58%	3.49TCr
CELLTRION, INC.	+1.22%	-1.44%	+14.57%	+46.95%	3.28TCr
INSMED INCORPORATED	+0.89%	+20.55%	-40.62%	+349.24%	2.47TCr
Average	+0.52%	+7.54%	+47.58%	+194.99%	4.38TCr
Weighted average by Cap.	+0.18%	+5.44%	+47.99%	+176.67%